| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Johnson EM et al. | Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. | 1998 | Antimicrob. Agents Chemother. | pmid:9624486 |
| Cosgrove RF and Fairbrother JE | Bioassay method for polyene antibiotics based on the measurement of rubidium efflux from rubidium-loaded yeast cells. | 1977 | Antimicrob. Agents Chemother. | pmid:319752 |
| Alonso MA et al. | Compounds affecting membranes that inhibit protein synthesis in yeast. | 1979 | Antimicrob. Agents Chemother. | pmid:394675 |
| González GM et al. | In vitro activities of free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis at various saprobic stages. | 2002 | Antimicrob. Agents Chemother. | pmid:11959606 |
| Gunderson SM et al. | In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect. | 2000 | Antimicrob. Agents Chemother. | pmid:10991881 |
| Kasbekar DP et al. | Self-induced nystatin resistance in Dictyostelium discoideum. | 1985 | Antimicrob. Agents Chemother. | pmid:4026273 |
| Boyce ST et al. | Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes. | 1995 | Antimicrob. Agents Chemother. | pmid:7574524 |
| Venables P and Russell AD | Nystatin-induced changes in Saccharomyces cerevisiae. | 1975 | Antimicrob. Agents Chemother. | pmid:1094947 |
| Tevyashova AN et al. | Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group. | 2013 | Antimicrob. Agents Chemother. | pmid:23716057 |
| Groll AH et al. | Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits. | 2000 | Antimicrob. Agents Chemother. | pmid:10722496 |
| Wallace TL et al. | Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. | 1997 | Antimicrob. Agents Chemother. | pmid:9333054 |
| Retamales P et al. | Complementation analysis with new genetic markers in Phaffia rhodozyma. | 1998 | Antonie Van Leeuwenhoek | pmid:9801767 |
| Kovalchik MT and Kraus SJ | Neisseria gonorrhoeae: colonial morphology of rectal isolates. | 1972 | Appl Microbiol | pmid:4624216 |
| Patel PV and Johnston JR | Dominant mutation for nystatin resistance in yeast. | 1968 | Appl Microbiol | pmid:5636460 |
| Huhtanen CN and Pensack JM | Effect of antifungal compounds on aspergillosis in hatching chick embryos. | 1967 | Appl Microbiol | pmid:5298442 |
| Merkal RS and Richards WD | Inhibition of fungal growth in the cultural isolation of mycobacteria. | 1972 | Appl Microbiol | pmid:4561102 |
| Plourde R and Hafez-Zedan H | Distribution of steroid 1-dehydrogenation and side-chain degradation enzymes in the spores of Fusarium solani: causes of metabolic lag and carbohydrate independence. | 1973 | Appl Microbiol | pmid:4699223 |
| James AN et al. | Variation in colonial morphology of Neisseria gonorrhoeae after growth on media containing antimicrobial agents. | 1973 | Appl Microbiol | pmid:4201640 |
| Wang W et al. | The interaction of polysaccharide from Auricularia polytricha with quantum dots and the protection of plasmid DNA from damage. | 2013 | Appl. Biochem. Biotechnol. | pmid:23440638 |
| Sanchez S et al. | Selective enrichment of aromatic amino acid auxotrophs in Hansenula polymorpha. | 1978 | Appl. Environ. Microbiol. | pmid:345964 |
| Volokhan O et al. | Characterization of the P450 monooxygenase NysL, responsible for C-10 hydroxylation during biosynthesis of the polyene macrolide antibiotic nystatin in Streptomyces noursei. | 2006 | Appl. Environ. Microbiol. | pmid:16597951 |
| Nedal A et al. | Analysis of the mycosamine biosynthesis and attachment genes in the nystatin biosynthetic gene cluster of Streptomyces noursei ATCC 11455. | 2007 | Appl. Environ. Microbiol. | pmid:17905880 |
| Gleeson MA et al. | Isolation of Candida tropicalis auxotrophic mutants. | 1990 | Appl. Environ. Microbiol. | pmid:2206102 |
| Brautaset T et al. | New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei. | 2011 | Appl. Environ. Microbiol. | pmid:21764946 |
| Kasbekar DP and Papavinasasundaram KG | An inducible, nondegradative phytoalexin resistance mechanism in Dictyostelium discoideum is suppressed by mutations that alter membrane sterol composition. | 1992 | Appl. Environ. Microbiol. | pmid:1622285 |
| Shobayashi M et al. | A new method for isolation of S-adenosylmethionine (SAM)-accumulating yeast. | 2006 | Appl. Microbiol. Biotechnol. | pmid:16010571 |
| Kim HJ et al. | Redesign of antifungal polyene glycosylation: engineered biosynthesis of disaccharide-modified NPP. | 2017 | Appl. Microbiol. Biotechnol. | pmid:28488115 |
| Lee MJ et al. | Structural analysis and biosynthetic engineering of a solubility-improved and less-hemolytic nystatin-like polyene in Pseudonocardia autotrophica. | 2012 | Appl. Microbiol. Biotechnol. | pmid:22382166 |
| Walmsley S et al. | Engineered biosynthesis and characterisation of disaccharide-modified 8-deoxyamphoteronolides. | 2017 | Appl. Microbiol. Biotechnol. | pmid:27858138 |
| Fjaervik E and Zotchev SB | Biosynthesis of the polyene macrolide antibiotic nystatin in Streptomyces noursei. | 2005 | Appl. Microbiol. Biotechnol. | pmid:15700127 |
| SPENCER MC | CLINICAL LIMITATIONS OF EXPERIMENTAL CUTANEOUS MONILIASIS (CANDIDA ALBICANS). | 1963 | Arch Dermatol | pmid:14071472 |
| Coskey RJ | Contact dermatitis due to nystatin. | 1971 | Arch Dermatol | pmid:5552354 |
| STONE OJ and MULLINS JF | EXPERIMENTAL STUDIES ON CHRONIC PARONYCHIA. | 1964 | Arch Dermatol | pmid:14096373 |
| Stroud JD and Van Dersarl JV | Striae. | 1971 | Arch Dermatol | pmid:5539499 |
| Cahill KM et al. | Primary cutaneous aspergillosis. | 1967 | Arch Dermatol | pmid:6054229 |
| White MI and Main RA | The treatment of Hallopeau's acrodermatitis. | 1979 | Arch Dermatol | pmid:426542 |
| Marples RR et al. | Topical steroid-antibiotic combinations: assay of use in experimentally induced human infections. | 1973 | Arch Dermatol | pmid:4579498 |
| Bradford LG and Montes LF | Perioral dermatitis and Candida albicans. | 1972 | Arch Dermatol | pmid:4555327 |
| Tio TH et al. | Subcutaneous phycomycosis. | 1966 | Arch Dermatol | pmid:5940919 |
| Coskey RJ and Bryan HG | Letter: Contact dermatitis due to perfume in Mycolog cream. | 1975 | Arch Dermatol | pmid:47237 |
| Chalmers D | Letter: Subclinical infection. | 1974 | Arch Dermatol | pmid:4852939 |
| Maize JC and Lynch PJ | Chronic mucocutaneous candidiasis of the adult. A report of a patient with an associated thymoma. | 1972 | Arch Dermatol | pmid:5009626 |
| Wasilewski C | Allergic contact dermatitis from nystatin. | 1971 | Arch Dermatol | pmid:5114421 |
| Chalmers D | Contact dermatitis due to nystatin. | 1971 | Arch Dermatol | pmid:5114422 |
| Coskey RJ and Paul L | Ampicillin sensitivity in infectious mononucleosis. | 1969 | Arch Dermatol | pmid:4312379 |
| Porter PS and Lyle JS | Yeast vulvovaginitis due to oral contraceptives. | 1966 | Arch Dermatol | pmid:5862627 |
| Petrozzi JW and Witkowski JA | Acrodermatitis perstans. Generalization following therapy with nystatin. | 1971 | Arch Dermatol | pmid:5091870 |
| Crutcher N et al. | Oral nystatin in the treatment of psoriasis. | 1984 | Arch Dermatol | pmid:6703746 |
| Wasilewski C | Allergic contact dermatitis from nystatin. | 1970 | Arch Dermatol | pmid:5430317 |
| Carter VH and Olansky S | Haloprogin and nystatin therapy for cutaneous candidiasis. Comparison of the efficacy of haloprogin and nystatin therapy. | 1974 | Arch Dermatol | pmid:4608934 |